Concepedia

Tadahiko Karasawa

TK

Statistics

Publications

30

Citations

1K

H-Index

20

Active since

1972

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Osaka City University

Tadahiko Karasawa is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1972–2014

30

Publications

30

Relationships Between Plasma Concentrations of Diphenylhydantoin, Phenobarbital, Carbamazepine, and 3‐Sulfamoylmethyl‐1,2‐Benzisoxazole (AD‐810), a New Anticonvulsant Agent, and Their Anticonvulsant or Neurotoxic Effects in Experimental Animals

Yuichi Masuda, Yuzo Utsui, Yuko Shiraishi et al. · Epilepsia · 1979 · 114 citations

AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.

Naoyuki Yoshida, T. Ito, Tadahiko Karasawa et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 82 citations

3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile.

Yuichi Masuda, Tadahiko Karasawa, Yuko Shiraishi et al. · PubMed · 1980 · 73 citations

, , +14

Inhibitory effect of zonisamide on human carbonic anhydrase in vitro.

Yuichi Masuda, Tadahiko Karasawa · PubMed · 1993 · 72 citations

, , +12

Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.

Makoto Oka, Yasutaka Noda, Y Ochi et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 55 citations · Full text

1–5 of 30